Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.39 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18905143 | 0.90 | MEN1 (0.41) | L3MBTL1MAPTLMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL8898680 | 0.90 | MAPT (0.47) | L3MBTL1MAPTLMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL18910301 | 0.89 | MRGPRX4 (0.46) | L3MBTL1MAPTLMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL1629303 | 0.89 | MAPT (0.53) | L3MBTL1MAPTLMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL20097747 | 0.88 | MEN1 (0.45) | L3MBTL1MAPTLMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL18905140 | 0.88 | MEN1 (0.45) | L3MBTL1MAPTLMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL1629158 | 0.87 | TSHR (0.43) | L3MBTL1MAPTLMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL1630676 | 0.87 | ALDH1A1 (0.51) | L3MBTL1MAPTLMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL18905142 | 0.86 | MEN1 (0.43) | L3MBTL1MAPTLMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL1630543 | 0.86 | MAPT (0.52) | L3MBTL1MAPTLMNASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9957402-B2 | Compound, active energy ray curable composition, cured article thereof, printing ink, and inkjet recording ink | DIC CORPORATION (JP) | 2018-05-01 | — | — | US | disclosed |
| US-20170152391-A1 | COMPOUND, ACTIVE ENERGY RAY CURABLE COMPOSITION, CURED ARTICLE THEREOF, PRINTING INK, AND INKJET RECORDING INK | DIC CORPORATION (JP) | 2017-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170152391-A1 | COMPOUND, ACTIVE ENERGY RAY CURABLE COMPOSITION, CURED ARTICLE THEREOF, PRINTING INK, AND INKJET RECORDING INK | CCNT1, EIF4A1, MARK1 | L3MBTL1 1010/4885MAPT 1180/4885LMNA 1590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.